GlassScriptPhysician profile
Chanel B Roper
NPI 1225486806
$3,056.47
in general payments reported to CMS, 2019-2025
33 companies · $11.26 in 2025
The $11.26 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $201 · 2021: $1,552 · 2022: $1,123 · 2025: $11.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $737.09 | 2020-2022 | |
| Gynesonics, INC. | $340.84 | 2022 | |
| Myovant Sciences INC. | $266.59 | 2021-2022 | |
| Minerva Surgical, INC | $248.99 | 2020-2021 | |
| Pfizer INC. | $168.09 | 2021-2022 | |
| Therapeuticsmd, INC. | $160.74 | 2020-2022 | |
| Coloplast Corp | $119.23 | 2021 | |
| Amniox Medical, INC. | $107.20 | 2019 | |
| Evofem Biosciences, INC. | $100.90 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $94.63 | 2021-2022 | |
| Astellas Pharma US INC | $90.88 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $88.93 | 2020-2021 | |
| Daiichi Sankyo INC. | $58.22 | 2021-2022 | |
| Virtus Pharmaceuticals LLC | $54.38 | 2021 | |
| Scynexis, INC. | $51.72 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $47.32 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $41.95 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $35.10 | 2022 | |
| Agile Therapeutics, INC. | $30.97 | 2021-2022 | |
| Lupin INC. | $23.27 | 2021 | |
| Mylan Pharmaceuticals INC. | $19.26 | 2022 | |
| Taiho Oncology, INC. | $17.82 | 2019 | |
| Avion Pharmaceuticals | $17.59 | 2022 | |
| Tesaro, INC. | $16.02 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.13 | 2021 | |
| Hologic Sales and Service, LLC | $14.99 | 2021 | |
| Axogen | $14.51 | 2019 | |
| Conmed Corporation | $13.47 | 2019 | |
| Mission Pharmacal Company | $13.40 | 2021 | |
| Merck Sharp & Dohme LLC | $12.52 | 2021 | |
| Allergan, INC. | $11.91 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.55 | 2021 | |
| Organon LLC | $11.26 | 2025 | Jada System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chanel Roper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.